Is Tilray Stock a Buy Post Fiscal Q2 Results? Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of…
Read MoreOffering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction
Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction Data from the Justice…
Read MoreCannabis poisoning in young children increased nine times after legalization
Cannabis poisoning in young children increased nine times after legalization Ontario saw nine times more emergency department visits per month…
Read MoreBrain-based method to determine impairment from cannabis intoxication
Brain-based method to determine impairment from cannabis intoxication A new study shows that imaging of brain activity with functional near-infrared…
Read MoreGenome-Wide Identification and Expression Profiles of bZIP Genes in Cannabis sativa L.
Genome-Wide Identification and Expression Profiles of bZIP Genes in Cannabis sativa L. Cannabis and Cannabinoid Research, Ahead of Print. Go…
Read More
Cannabis in 2022 – Hurry Up and Wait
Cannabis in 2022 – Hurry Up and Wait Here we are entering a new year. Finally, many states in the…
Read More
Top Five Insurances Cannabis Businesses Need in 2022
Top Five Insurances Cannabis Businesses Need in 2022 Cannabis remains one of the fastest growing industries with no signs of…
Read More
Where the Cannabis Industry is Headed in 2022
Where the Cannabis Industry is Headed in 2022 Federal legalization of adult use cannabis is still out there as a…
Read More